A new neurological entity manifesting as involuntary movements and dysarthria with possible abnormal copper metabolism
- aDepartment of Neurology, Teikyo University School of Medicine, Ichihara Hospital, 3426–3 Anesaki, Ichihara City, Chiba 299–0111, Japan, bDepartment of Neurology, National Sanatorium Chiba East Hospital
- Dr A Tagawa
- Received 30 April 2001
- Accepted 25 July 2001
A few patients with an affected CNS involving abnormalities in copper metabolism have been described that do not fit any known nosological entities such as Wilson's disease or Menkes' disease.
Three sporadic patients (two men and one woman) were examined with involuntary movements and dysarthria associated with abnormal concentrations of serum copper, serum ceruloplasmin, and urinary copper excretion. The onset of neurological symptoms occurred at the age of 15 to 17 years. The common clinical symptoms were involuntary movements and dysarthria. The involuntary movements included dystonia in the neck, myoclonus in the shoulder, athetosis in the neck, and rapid orobuccal movements. The dysarthria consisted of unclear, slow, and stuttering speech. Two of the three patients did not have dementia. A cousin of the female patient had been diagnosed as having Wilson's disease and had died of liver cirrhosis. Laboratory findings showed a mild reduction in serum copper and ceruloplasmin concentrations, whereas urinary copper excretion was significantly reduced in all three patients. Two of the three patients showed a high signal intensity in the basal ganglia on T2 weighted brain MRI.
In conclusion, the unique findings of involuntary movements, dysarthria, and abnormal serum copper and urinary copper concentrations suggest that the three patients may constitute a new clinical entity that is distinct from either Wilson's or Menkes disease.
Abnormalities in copper metabolism have been described in some diseases affecting the CNS, including Wilson's disease,1 Menkes' disease,2 aceruloplasminaemia,3 and other unclassified disorders.4-7 We describe three patients with involuntary movements, dysarthria, and mildly low concentrations of serum copper and ceruloplasmin. These three patients also showed a significant reduction in urinary copper excretions suggesting an abnormal copper metabolism. Two of the patients exhibited abnormal signal intensities in the basal ganglia on T2 weighted brain MRI. The patients described here do not resemble other previously described patients.
A 35 year old woman had had a tremor in her right upper limb and dystonia in the neck for 18 years. She was admitted to our hospital after developing dysarthria and oral dyskinesia. On admission, she was fully conscious. A Weschler adult intelligence scale (WAIS-R) test disclosed a verbal IQ of 70, a performance IQ of 69, and a full scale IQ of 66. She exhibited a slow speech pattern, mild oral dyskinesia, and action tremors in the upper limbs. Her neck had a dystonic posture, and her muscle tone was moderately increased. Kayser-Fleisher rings were not seen. The optic fundus was normal. Laboratory findings showed a haemoglobin concentration of 9.5 g/dl, and a depressed serum iron concentration of 40 μg/dl. Liver function was normal. Her serum copper concentration was mildly depressed at 88 μg/dl (normal values 103–159 μg/dl), and her ceruloplasmin concentration was 24.9 mg/dl (normal values 14.9–38.4 mg/dl). Urinary copper excretion decreased to less than than 20 μg/day. An abdominal ultrasonography and abdominal CT showed no abnormalities, and a liver biopsy showed no accumulation of copper. T2 weighted brain MRI showed a slightly high signal intensity in bilaterally in the putamen (fig 1). Her cousin had been diagnosed as having Wilson's disease at another hospital and had died from liver cirrhosis at the age of 20 years. A consanguineous marriage had occurred among her relatives.
A 37 year old man had been healthy until the age of 22, when he developed muscle rigidity in his right leg and an action tremor in his right hand. He began to stutter and speech became monotonous. He visited another hospital for a consultation and was suspected of having Wilson's disease because his serum copper and ceruloplasmin concentrations were slightly low and abnormal intensity in the basal ganglia was seen on a brain MRI. Oral penicillamine therapy was started. Although his urinary copper excretion had been depressed during his basal condition, no obvious increase was found after the initiation of penicillamin therapy. No deterioration in clinical symptoms was seen. Twelve years later, he visited our hospital for a re-examination. At this time, his mental status was normal. He stuttered and had a monotonous speech pattern. Mild muscle rigidity and slight clumsiness were seen in the right upper and lower limbs. He sometimes showed myoclonic involuntary movements in his shoulder and athetotic movements of the neck when he wrote. Kayser-Fleischer rings were not seen. The optic fundus showed no abnormalities. Thyroid and liver functions were normal, as was his serum iron concentration. His serum copper concentration was depressed to 65 μg/dl (normal: 80–130 μg/dl), and ceruloplasmin concentration was 15.5 mg/dl (normal:16.0–31.0 mg/dl). After the withdrawal of penicillamine, his urinary copper excretion decreased significantly to less than 10 μg/day. An abdominal CT showed no signs of abnormalities and a liver biopsy disclosed no abnormal deposits of copper. T2 weighted brain MRI showed a high signal intensity that was dominant in the left caudate nucleus and the lateral margin of the putamen (fig 2). A genetic study showed no mutation in the genes responsible for Wilson's disease. His symptoms remain unchanged.
A 26 year old man presented with a 10 year history of frequent palpebrations. He developed orobuccal involuntary movements at the age of 20 years. He visited another hospital for a consultation and was found to have low serum copper and ceruloplasmin values. He was admitted to our hospital for further examination. He was alert on admission. A WAIS-R test disclosed a verbal IQ of 87, a performance IQ of 106, and a full scale IQ of 94. He exhibited rapid orofacial involuntary movements and slightly unclear speech. Muscle tone was normal in all limbs. Kayser-Fleischer rings were not seen. The optic fundus was normal. Liver and thyroid functions were also normal. His serum copper concentration was 61 μg/dl (normal: 82∼134 μg/dl), and his ceruloplasmin concentration was 15.1 mg/dl (normal 20.0–37.0 mg/dl). His urinary copper excretion concentration was less than 10 μg/day. Brain MRI and abdominal CT showed no signs of abnormalities. A liver biopsy found no abnormal deposits of copper. His involuntary movements slightly improved with oral medication of pimozide.
As shown in table 1, the common clinical and laboratory features of the present three patients were involuntary movements, dysarthria, slightly low concentrations of serum copper and ceruloplasmin, and a reduction in urinary copper excretion. These features suggested the presence of abnormal copper metabolism. Two of the three patients showed no signs of dementia, and liver function was normal in all three patients (table 1). The presence of a relative who had been diagnosed as having Wilson's disease is significant in patient 1. Moreover, the high signal intensities in the basal ganglia on T2 weighted brain MRI in patients 1 and 2 imply that a mineral has been deposited in this area.
Copper is required for the catalytic activity of enzymes that play essential prts in neurobiology and pathogenesis, including tyrosinase for melanin synthesis, cytochrome-c oxidase for electron transport in the mitochondrial respiratory chain, Cu/Zn superoxide dismutase for antioxidant defence, dopamine hydroxylase for catecholamine biosynthesis, and ceruloplasmin for brain iron homeostasis.8 Some diseases affecting the CNS involve abnormalities in copper metabolism, such as Wilson's disease,1 Menkes' disease,2aceruloplasminaemia,3 amyotrophic lateral sclerosis,8 Alzheimer's disease,8 prion disease,8 and a few other diseases.4-7
Patients with Wilson's disease exhibit a high signal intensity on T2 weighted brain MRI9 due to abnormal copper deposition. Therefore, some of the clinical aspects and brain MRI findings seen in our patients are similar to those for Wilson's disease. Wilson's disease is an autosomal recessive disorder. Patients may be either homozygous or heterozygous,10 and various clinical manifestations11have been reported. For instance, some patients that do not show Kayser-Fleischer rings12 13 or have normal serum ceruloplasmin concentrations14 have been reported. Most patients with Wilson's disease can show a raised concentration of urinary copper excretion and mild clinical symptoms; these features are strikingly different from those found in our patients. Some case reports describing normal urinary copper excretion concentrations under basal conditions in heterozygous10and asymptomatic patients11 with Wilson's disease have been made. In the 16 asymptomatic patients described by Mareceket al,10 urinary copper excretion was normal in the basal condition and increased significantly after penicillamine therapy. Unlike these findings, urinary copper excretion did not obviously increase after penicillamine therapy in patient 2. No case of Wilson's disease associated with a decrease in urinary copper excretion has been reported. Therefore, the pathophysiological mechanism of our patients is distinct from that of Wilson's disease.
Menkes' disease2 is a disorder in which copper absorption in the gastrointestinal tract is disturbed. It is an X linked recessive disease that causes severe mental retardation and cerebellar ataxia in early childhood. The clinical features of Menkes' disease are different from those of the patients described here.
Aceruloplasminaemia3 is an autosomal recessive disorder resulting from inherited mutations in the ceruloplasmin gene. Patients with acerulolasminaemia do not have copper deposition in their organs, but have significantly increased iron concentrations in both their hepatocytes and the basal ganglia. The iron deposits produce an increase in low signal intensities in the basal ganglia on T2 weghted brain MRI, which is different from our findings.
A few patients similar to ours have been reported in the literature4-7; these patients showed signs of CNS involvement and the existence of an abnormality in copper metabolism different from that found in Wilson's disease and Menkes' disease. The patients described by Ono and Kurisaki4 and Godwin-Austen et al 5 were sporadic and showed mildly low concentrations of serum copper and ceruloplasmin. As in our patients, urinary copper excretion was reduced, and the accumulation of copper was not found. However, two of our patients showed no dementia, unlike the patients reported by Ono and Kurisaki4 and Godwin-Austen et al.5
Haas et al 6 and Willvonsder et al 7 reported a new X linked recessive disorder resulting in an abnormal copper metabolism that was distinct from Menkes' disease. Their cases showed dysarthria, involuntary movements and mildly reduced serum copper and ceruloplasmin concentrations. However, all of their patients showed dementia, and the patients described by Willvonsderet al 7 exhibited normal concentrations of urinary copper excretion. Thus, the findings of the above studies are quite different from ours.
Our three unique patients showing dysarthria, involuntary movements, and abnormal serum and urinary copper values may constitute a new clinical entity distinct from Wilson's disease and other previously described disorders.